๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Increased arachidonic acid incorporation into platelet phospholipids in Type 2 (non-insulin-dependent) diabetes

โœ Scribed by R. Takahashi; I. Morita; Y. Saito; H. Ito; S. Murota


Publisher
Springer
Year
1984
Tongue
English
Weight
451 KB
Volume
26
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Arachidonic acid uptake activity was measured in platelets obtained from 27 Type 2 diabetic patients and 18 age-matched control subjects. In both groups after 1 h incubation almost all the incorporated 14C-arachidonic acid was located in the phospholipids of the platelets. Arachidonic acid was predominantly incorporated into phosphatidylcholine. The radioactivity incorporated into platelets increased linearly with incubation time, up to 90 min. The linear increase was observed at arachidonic acid concentrations of 0.1-1.0 micrograms/ml in both groups. The rate of incorporation of radioactivity in diabetic platelets was about 1.4 times higher than that in control platelets at all arachidonic acid concentrations studied. The arachidonic acid uptake activity of diabetic platelets (577 +/- 26 ng/60 min per 10(9) platelets) was significantly higher than that in control platelets (410 +/- 26 ng/60 min per 10(9) platelets). No significant correlations were found between the arachidonic acid uptake activity and fasting plasma glucose, total cholesterol or triglyceride levels. The arachidonic acid uptake activity of platelets was significantly higher in diabetic patients with proliferative retinopathy than in those with little or no background retinopathy. In addition, there were no significant differences between control and diabetic subjects in the uptake activity of platelets for linoleic acid and oleic acid. These data may explain the elevated arachidonic acid content in diabetic platelet phospholipids and enhancement of thromboxane synthesis in diabetes.


๐Ÿ“œ SIMILAR VOLUMES


Increased intracellular calcium mobiliza
โœ H. Ishii; F. Umeda; T. Hashimoto; H. Nawata ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 543 KB

## Enhanced platelet functions have been reported in patients with diabetes mellitus. Our recent study demonstrated that phosphoinositide turnover is increased in platelets from diabetic patients. In the present study, we evaluated the abnormality in platelet intracellular calcium mobilization in

Effect of ฮฑ2-adrenoceptor antagonist on
โœ H. Takeda; H. Kishikawa; M. Shinohara; T. Miyata; K. Suzaki; H. Fukushima; K. Ic ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 720 KB

The role of epinephrine in platelet activation and the effect of an alpha 2-adrenoceptor antagonist, midaglizole, during insulin-induced hypoglycaemia in Type 2 (non-insulin-dependent) diabetes mellitus were examined. The action of midaglizole as a platelet alpha 2-antagonist was confirmed by in vit

Non-esterified fatty acids do not contri
โœ J. Eriksson; C. Saloranta; E. Widรฉn; A. Ekstrand; A. Franssila-Kallunki; C. Scha ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 659 KB

The mechanisms underlying insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus are not fully understood. An enhanced lipid/non-esterified fatty acid oxidation could provide an explanation. To test this hypothesis we examined the relationship between glucose and lipid metabolism in

Effect of ฮฑa-adrenoceptor antagonist on
โœ D. P. Mikhailidis ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 282 KB

## Is a low insulin response to intravenous glucose an marker of Type 1 (insulin-dependent) diabetes? Dear Sir, Recently B. Vialettes et al. published the results of a study to determine the value of low acute insulin response to intravenous glucose as a marker of early stages of Type i (insulin-d